CRISPR-Cascade test detects bloodstream infections in minutes without amplification
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting bloodstream infections in minutes without the need for nucleic acid amplification. The CRISPR-Cascade assay achieves attomolar sensitivity and incorporates an OR-gated logic function to identify multiple pathogens simultaneously through DNA from pathogens associated with bloodstream infections. Bloodstream infections require rapid identification to prevent complications, yet standard diagnostic methods rely on...
Related Coverage
AllSides Picks
Headline Roundup
Meta Agrees to New Facebook, Instagram Limits for Teens in $18 Billion Settlement
August 26th, 2026
Story of the Week
Meta Settles with 29 States
AllSides Staff
August 27th, 2026
The Insight
The Insight: Back to School, Behind on Reading: Why America’s Literacy Crisis Persists
AllSides Staff
August 21st, 2026
Red Blue Translator